These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2585532)

  • 1. Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.
    Abbruzzese JL; Weeks A; Raber MN; Gravel D; DuBrow RA; Levin B; Grem J; Chun HG
    J Natl Cancer Inst; 1989 Dec; 81(23):1840-2. PubMed ID: 2585532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant treatment of rectal carcinoma: also a step forward?].
    Wagener DJ; Wils JA
    Ned Tijdschr Geneeskd; 1992 Mar; 136(11):502-3. PubMed ID: 1552951
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
    J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
    Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P
    Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose weekly oral leucovorin and 5-fluorouracil in previously untreated patients with advanced colorectal carcinoma: a phase I study.
    Hines JD; Adelstein DJ; Spiess JL; Carter SG; Trey JE
    Adv Exp Med Biol; 1988; 244():167-72. PubMed ID: 3266823
    [No Abstract]   [Full Text] [Related]  

  • 6. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.
    Cunningham D; Zalcberg JR; Rath U; Oliver I; van Cutsem E; Svensson C; Seitz JF; Harper P; Kerr D; Perez-Manga G
    Ann Oncol; 1996 Nov; 7(9):961-5. PubMed ID: 9006748
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
    Di Costanzo F; Malacarne P; Zironi S; Marzola M; Cornia E; Figoli F; Bacchi M; Passalacqua R; Algeri R; Bartolucci R
    J Surg Oncol Suppl; 1991; 2():137-40. PubMed ID: 1892522
    [No Abstract]   [Full Text] [Related]  

  • 8. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
    Venook AP; Blanke CD; Niedzwiecki D; Lenz HJ; Taylor JR; Hollis DR; Sutherland S; Goldberg RM
    Clin Colorectal Cancer; 2007 May; 6(7):536-8. PubMed ID: 17553204
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil.
    Nozue M; Isaka N; Maruyama T; Kawamoto T; Seino KI; Tanagichi H; Fukao K
    Oncol Rep; 2002; 9(1):93-6. PubMed ID: 11748463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
    Underhill C; Goldstein D; Gorbounova VA; Biakhov MY; Bazin IS; Granov DA; Hossain AM; Blatter J; Kaiser C; Ma D
    Oncology; 2007; 73(1-2):9-20. PubMed ID: 18334829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: a phase II study.
    Yang TS; Chen JS; Tang R; Chiang JM; Hsieh PS; Yeh CY; Changchien CR
    Chemotherapy; 2003 Jul; 49(4):194-9. PubMed ID: 12886055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronomodulated chemotherapy in advanced colorectal carcinoma.
    Price T; Karapetis C
    J Clin Oncol; 2002 Sep; 20(18):3937-8; author reply 3938-9. PubMed ID: 12228219
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.
    Scheithauer W; Depisch D; Schiessel R; Ludwig H
    Oncology; 1989; 46(4):217-21. PubMed ID: 2787010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
    Kang EJ; Choi YJ; Kim JS; Kim ST; Park KH; Choi IK; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma.
    Petrelli NJ; Rustum YM; Bruckner H; Stablein D
    Adv Exp Med Biol; 1988; 244():143-55. PubMed ID: 3073651
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
    Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial.
    DeCaprio JA; Mayer RJ; Gonin R; Arbuck SG
    J Clin Oncol; 1991 Dec; 9(12):2128-33. PubMed ID: 1960554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.